Benjamin Shapiro Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

ORMP Quotes by TradingView

Benjamin Shapiro is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 123,220 shares of ORMP, which is worth approximately $293,263. The most recent transaction as insider was on Dec 31, 2025, when has been sold 33,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
37.34% 3M change
123.75% 12M change
Total Value Held $293,263

Benjamin Shapiro Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Grant, award, or other acquisition
-
33,500 Added 21.38%
123,220 Common Stock
Jun 05 2025
BUY
Grant, award, or other acquisition
-
34,650 Added 27.86%
89,720 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
35,070 Added 38.91%
55,070 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock
BS

Benjamin Shapiro

Director
New York, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORMP